SEC Comment Letter for ACORDA THERAPEUTICS INC (CIK 0001008848) — Jan 22, 2020

ACORDA THERAPEUTICS INC (CIK 0001008848)
Date: Jan. 22, 2020 · CIK: 0001008848 · Accession: 0000000000-20-000531

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-235929

Date

January 21, 2020

Author

Not clearly detected

Form

UPLOAD

Company

ACORDA THERAPEUTICS INC (CIK 0001008848)

Letter

January 21, 2020 Ron Cohen President and Chief Executive Officer Acorda Therapeutics, Inc. 420 Saw Mill River Road Ardsley, New York 10502 Re:Acorda Therapeutics, Inc. Registration Statement on Form S-3 Filed January 15, 2020 File No. 333-235929 Dear Dr. Cohen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

January 21, 2020
Ron Cohen
President and Chief Executive Officer
Acorda Therapeutics, Inc.
420 Saw Mill River Road
Ardsley, New York 10502
Re:Acorda Therapeutics, Inc.
Registration Statement on Form S-3
Filed January 15, 2020
File No. 333-235929
Dear Dr. Cohen:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io